Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b0c198757da18cf77dfbdcef00abb70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b3e6d16e5e895914f023d28f1d137ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea57db10fe6e572d4a54808447081e9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2013-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e74f4b8cf5538830df4955149565021e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09a3ab71788a92c288350bf7316d679e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead8ff7b288572a219b35b662ab928c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_753758d9daf7f673ec74bd4a764a819e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebcb1d48c38df84b2d45015dc468531e |
publicationDate |
2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014080732-A1 |
titleOfInvention |
Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
abstract |
The present invention includes methods, systems and kits for distinguishing between active and latent mycobacterium tuberculosis infection in a patient suspected of being infected with Mycobacterium tuberculosis , the method including the steps of obtaining a patient gene expression dataset from a patient suspected of being infected with Mycobacterium tuberculosis ; sorting the patient gene expression dataset into one or more gene modules associated with Mycobacterium tuberculosis infection; and comparing the patient gene expression dataset for each of the one or more gene modules to a gene expression dataset from a non-patient; wherein an increase or decrease in the totality of gene expression in the patient gene expression dataset for the one or more gene modules is indicative of active Mycobacterium tuberculosis infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3132270-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016340121-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018291452-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10920275-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10041945-B2 |
priorityDate |
2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |